This is a StreetInsider.com Premium Only Page

InVitae (NVTA) –

Apr 11, 2024 11:30 AM Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance

Apr 4, 2024 04:05 PM Form 8-K Invitae Corp For: Mar 29

Mar 12, 2024 07:30 AM Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification

Mar 6, 2024 07:15 AM Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results

Mar 5, 2024 07:30 AM Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting

Feb 21, 2024 09:00 AM Form 25-NSE Invitae Corp Filed by: NEW YORK STOCK EXCHANGE LLC

Feb 14, 2024 07:00 AM Form 8-K Invitae Corp For: Feb 13

Feb 14, 2024 05:46 AM InVitae (NVTA) Files for Chapter 11

Feb 13, 2024 10:07 PM Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process

Feb 13, 2024 05:12 PM Form SC 13G/A Invitae Corp Filed by: VANGUARD GROUP INC

Feb 13, 2024 09:11 AM Form SC 13G/A Invitae Corp Filed by: Nikko Asset Management Americas, Inc.

Feb 6, 2024 05:08 PM Form 8-K Invitae Corp For: Feb 06

Feb 6, 2024 09:06 AM NYSE to Commence Delisting of InVitae (NVTA)

Feb 5, 2024 02:44 PM InVitae (NVTA) Halted, News Pending

Feb 5, 2024 12:16 PM Invitae prepares for bankruptcy - WSJ

Feb 5, 2024 11:10 AM InVitae (NVTA) Hires FTI, Kirkland & Ellis to Advise Options to Address $1.5 Billion of Debt - WSJ

Feb 5, 2024 06:09 AM Form SC 13G/A Invitae Corp Filed by: Sumitomo Mitsui Trust Holdings, Inc.

Jan 30, 2024 07:00 AM Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics

Jan 29, 2024 04:02 PM Form SC 13G/A Invitae Corp Filed by: ARK Investment Management LLC

Jan 29, 2024 03:28 PM Form SC 13G/A Invitae Corp Filed by: BlackRock Inc.

Jan 24, 2024 04:34 PM Form 8-K/A Invitae Corp For: Jan 17

Jan 22, 2024 07:05 AM Form 8-K Invitae Corp For: Jan 17

Jan 22, 2024 07:01 AM InVitae (NVTA) Completes Sale of Reproductive Health Assets to Natera (NTRA)

Jan 22, 2024 07:00 AM Invitae Completes Sale of Reproductive Health Assets to Natera

Jan 22, 2024 07:00 AM Natera Acquires Reproductive Health Assets from Invitae

Jan 18, 2024 04:11 PM Form 8-K Invitae Corp For: Jan 11

Jan 12, 2024 06:01 AM Form 8-K/A Invitae Corp For: Dec 13

Dec 21, 2023 09:21 PM Form 4 Invitae Corp For: Dec 20 Filed by: Nussbaum Robert L

Dec 21, 2023 09:15 PM Form 4 Invitae Corp For: Dec 20 Filed by: Brida Thomas

Dec 14, 2023 04:30 PM Form 8-K Invitae Corp For: Dec 13

Dec 13, 2023 04:07 PM InVitae (NVTA) Divests Ciitizen Health Data Platform, Implements Further Cost Cuts

Dec 13, 2023 04:07 PM Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

Dec 11, 2023 04:42 PM Form 8-K Invitae Corp For: Dec 07

Nov 17, 2023 04:49 PM Form 8-K Invitae Corp For: Nov 17

Nov 15, 2023 04:36 PM InVitae (NVTA) Sells YouScript to Aranscia

Nov 15, 2023 04:35 PM Aranscia Acquires YouScript from Invitae

Nov 15, 2023 04:23 PM Form 8-K Invitae Corp For: Nov 10

Nov 14, 2023 08:13 PM Form 3 Invitae Corp For: Nov 13 Filed by: Sholehvar David

Nov 14, 2023 08:13 PM Form 4 Invitae Corp For: Nov 13 Filed by: Sholehvar David

Nov 8, 2023 04:36 PM Form 10-Q Invitae Corp For: Sep 30

Nov 8, 2023 04:06 PM Form 8-K Invitae Corp For: Nov 08

Nov 8, 2023 04:04 PM InVitae (NVTA) Tops Q3 EPS by 22c

Nov 8, 2023 04:01 PM Invitae Reports Third Quarter 2023 Financial Results

Nov 6, 2023 04:00 PM InVitae (NVTA) Launches Enhanced Chemistry of MRD Test

Nov 6, 2023 04:00 PM Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships

Nov 1, 2023 06:59 AM Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

Oct 25, 2023 11:00 AM Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results

Oct 23, 2023 06:07 AM Invitae Corporation (NVTA) PT Lowered to $0.50 at Goldman Sachs

Oct 20, 2023 06:05 PM Form 4 Invitae Corp For: Oct 18 Filed by: Brida Thomas

Oct 20, 2023 06:05 AM Invitae Corporation (NVTA) PT Lowered to $0.50 at Goldman Sachs